Biogen (BIIB) EPS (Basic) (2009 - 2026)
Biogen (BIIB) recorded quarterly EPS (Basic) of $2.17 in Q1 2026, up 757.58% quarter-over-quarter from -$0.33 in Q4 2025, and up 31.52% on a YoY basis from $1.65 in Q1 2025.
Biogen (BIIB) EPS (Basic) (2009 - 2026) Analysis & Trends
Biogen's EPS (Basic) history runs 18 years deep, the most recent figure standing at $2.17 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 31.52% year-over-year to $2.17; the TTM figure through Mar 2026 stood at $9.35 (down 7.97% YoY), while the FY2025 annual figure was $8.83, down 21.23% from the prior year.
- EPS (Basic) was $2.17 for Q1 2026 at Biogen, up from -$0.33 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $7.86 in Q3 2022 to a low of -$0.47 in Q3 2023.
- Historically, EPS (Basic) has averaged $3.02 across 5 years, with a median of $2.69 in 2023.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 668.09% in 2024, then plunged 118.03% in 2025.
- A 5-year view of EPS (Basic) shows it stood at $3.84 in 2022, then slumped by 55.21% to $1.72 in 2023, then advanced by 6.4% to $1.83 in 2024, then slumped by 118.03% to -$0.33 in 2025, then jumped by 757.58% to $2.17 in 2026.
- The last three EPS (Basic) figures came in at $2.17 (Q1 2026), -$0.33 (Q4 2025), and $3.18 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 0.00 |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 8.27 |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 2.17 |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 0.39 |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -1.72 |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 3.37 |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 1.63 |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 0.48 |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 1.31 |
| 10 | Biogen | 28.75 Bn | 24.47 Bn | 1.82 Bn | 2.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.17 |
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | 3.18 |
| Jun 30, 2025 | 4.33 |
| Mar 31, 2025 | 1.65 |
| Dec 31, 2024 | 1.83 |
| Sep 30, 2024 | 2.67 |
| Jun 30, 2024 | 4.01 |
| Mar 31, 2024 | 2.71 |
| Dec 31, 2023 | 1.72 |
| Sep 30, 2023 | -0.47 |
| Jun 30, 2023 | 4.09 |
| Mar 31, 2023 | 2.69 |
| Dec 31, 2022 | 3.84 |
| Sep 30, 2022 | 7.86 |
| Jun 30, 2022 | 7.25 |
| Mar 31, 2022 | 2.06 |
| Dec 31, 2021 | 2.51 |
| Sep 30, 2021 | 2.22 |
| Jun 30, 2021 | 3.00 |